More Questions Than Answers: A Narrative Review of the Epidemiology, Risk Factors, and Outcomes of Postoperative Atrial Fibrillation

Robert N. Bilkovski, Jo Ann K. LeQuang, and Joseph Pergolizzi Jr.

Cureus 18(2): e103283, Feb 9, 2026. DOI: 10.7759/cureus.103283

https://pmc.ncbi.nlm.nih.gov/articles/PMC12978295/pdf/cureus-0018-00000103283.pdf

​

Endocarditis - Diagnosis and Treatment

Peter Magnusson, Joseph V. Pergolizzi, Payam Behzadi, and Jo Ann LeQuang. 10.5772/intechopen.100932, Nov 8, 2023. ISBN978-1-80356-741-9

https://www.intechopen.com/books/11659

​​

Seven Things We Need to Know about Postoperative Atrial Fibrillation: Editorial

Joseph V. Pergolizzi Jr., Jo Ann LeQuang, and Peter Magnusson

21st Century Cardiology, Volume 1 (2): 110, Nov 28, 2021.

https://21stcenturycardiology.com/articles/seven-things-we-need-to-know-about-postoperative-atrial-fibrillation-editorial.html

​

Ultralow energy cardioversion in a pig model of atrial fibrillation: A feasibility study

Abdelmotagaly Elgalad, MD, PhD,* Angel Moctezuma-Ramirez, MD,*Cristiano de Oliveira Cardoso, MD, PhD,* Mathews John, MBE,† Joseph Pergolizzi, MD,‡Randall K. Wolf, MDx

From the *Center for Preclinical Surgical & Interventional Research, Texas Heart Institute, Houston, Texas, †Electrophysiology Clinical Research & Innovations, Texas Heart Institute, Houston, Texas, ‡NativeCardio Inc., Naples, Florida, and xDeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.

https://www.heartrhythmjournal.com/article/S1547-5271(22)00093-5/fulltext

 

The Subcutaneous Implantable Cardioverter-Defibrillator

By: Peter Magnusson, Joseph V. Pergolizzi and Jo Ann LeQuang

https://www.intechopen.com/profiles/263908

 

Atrial Fibrillation and the Role of Thumb ECGs

Peter Magnusson, Magnus Samuelsson, Joseph V. Pergolizzi, Hani Annabi,  and Jo Ann LeQuang

DOI:10.5772/INTECHOPEN.83660

https://www.wizdom.ai/publication/10.5772/INTECHOPEN.83660/title/atrial_fibrillation_and_the_role_of_thumb_ecgs#:~:text=DOI%3A%2010.5772,Jo%20Ann%20LeQuang

 

 

NOAC (Novel or non-vitamin-K antagonists ) in Patients with a Single CHA2DS2-VASc Risk Factor

Joseph V Pergolizzi Jr ... Magnusson P, Pergolizzi J Jr., Wolf RK, Lamberts M, LeQuang JA (2019) Anticoagulation in Atrial ... Intech Open.

https://www.scholarsliterature.com/journals/international-journal-of-integrative-cardiology/fulltext/noac-in-patients-with-a-single-cha2ds2-vasc-risk-factor

 

 

Postoperative Pain Control Following Cardiac Implantable Electronic Device Implantation

By: Peter Magnusson, Jo Ann LeQuang, and Joseph V. Pergolizzi.

'IntechOpen' DOI:10.5772/intechopen.101517 oai:intechopen.com:79644

https://core.ac.uk/display/484065829?source=2

 

Anticoagulation in Atrial Fibrillation Patients

By: Peter Magnusson, Joseph V. Pergolizzi, Randall K. Wolf, Morten Lamberts, and Jo Ann LeQuang

DOI: 10.5772/intechopen.88965 IntechOpen

https://core.ac.uk/display/322444649?source=2

 

Sudden Cardiac Death: Chapter Four: the Wearable Cardioverter Defibrillator

By: Peter Magnusson, Jo Ann LeQuang, Joseph V. Pergolizzi, 

https://books.google.com/books?id=jmstEAAAQBAJ&pg=PP5&lpg=PP5&dq=pergolizzi+intech+open&source=bl&ots=qx3z3mXlbY&sig=ACfU3U36i7x8PoEy5WFLZ_VrItJxcEbo6A&hl=en&sa=X&ved=2ahUKEwjJ1LjO0Iv-AhWSSTABHWoEA9Y4MhDoAXoECAUQAw#v=onepage&q=pergolizzi%20intech%20open&f=false